APPENDICES - NIHR Health Technology Assessment Programme

DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37
Two hundred and thirty-five publications, with
study designs that did not meet the inclusion
criteria for the review, reported on patients with
skin cancer being treated with PDT. The references
are listed below in alphabetical order; they have not
been categorised and may still contain a number of
duplicate publications.
References
1. Abels C, Karrer S, Baumler W, Goetz AE,
Landthaler M, Szeimies RM. Indocyanine
green and laser light for the treatment of AIDSassociated
cutaneous Kaposi’s sarcoma. Br J Cancer
1998;77:1021–4.
2. Alecu M, Ursaciuc C, Halalau F, Coman G,
Merlevede W, Waelkens E, et al. Photodynamic
treatment of basal cell carcinoma and squamous
cell carcinoma with hypericin. Anticancer Res
1998;18:4651–4.
3. Allison RR, Mang TS, Wilson BD, Vongtama V. Tin
ethyl etiopurpurin-induced photodynamic therapy
for the treatment of human immunodeficiency
virus-associated Kaposi’s sarcoma. Curr Ther Res
Clin Exp 1998;59:23–7.
4. Alvanopoulos K, Antoniou C, Melpo P, Vareltzidis
A, Katsambas A. Photodynamic therapy of
superficial basal cell carcinomas using exogenous
5-aminolevulinic acid and 514-nm light. J Eur Acad
Dermatol Venereol 1997;9:134–6.
5. Antoniou C, Katsambas A, Rigopoulos D, Palaskas
E, Tsikrikas GN. Aminolevulinic acid: topical
photodynamic therapy in skin cancers and solar
keratoses. Skin Cancer 1996;11:81–4.
6. Attili S, Cochrane A, McNeill A, Camacho-Lopez
M, Moseley H, Ibbotson S, et al. An open pilot
study of ambulatory photodynamic therapy using a
wearable, low-irradiance, organic LED light source
in the treatment of nonmelanoma skin cancer. Br J
Dermatol 2008;159:130–1.
7. Baas P, Saarnak AE, Oppelaar H, Neering H,
Stewart FA. Photodynamic therapy with metatetrahydroxyphenylchlorin
for basal cell carcinoma:
a phase I/II study. Br J Dermatol 2001;145:75–8.
8. Bagnato VS, Kurachi C, Ferreira J, Marcassa
LG, Sibata CH, Allison RR. PDT experience in
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
Appendix 6
Skin cancer scoping
Brazil: a regional profile. Photodiag Photodyn Ther
2005;2:107–18.
9. Bakos RM, Bakos L, Ferlin E, Cestari T, Orlandini T,
Rezende R, et al. [Photodynamic therapy with deltaaminolevulinic
acid for superficial keratinocytic
neoplasms.] An Bras Dermatol 2003;78:197–207.
10. Bandieramonte G, Marchesini R, Melloni E,
Andreoli C, di Pietro S, Spinelli P, et al. Laser
phototherapy following HpD administration in
superficial neoplastic lesions. Tumori 1984;70:327–
34.
11. Baptista J, Martinez C, Leite L, Cochito M. Our
PDT experience in the treatment of non-melanoma
skin cancer over the last 7 years. J Eur Acad Dermatol
Venereol 2006;20:693–7.
12. Baron E, Domingo DS, Hsia A, Colussi V,
Oleinick N, Foster T, et al. Silicon phthalocyanine
photodynamic therapy for treatment of cutaneous
neoplasms. J Invest Dermatol 2008;128:395.
13. Baron ED, Hanneman K, Scull HM, Hsia
A, McCormick T, Oleinick NL, et al. Silicon
phthalocyanine (Pc 4) photodynamic therapy for
the treatment of pre-malignant and malignant
skin conditions: an update. J Invest Dermatol
2005;125:942.
14. Bendsoe N, Persson L, Johansson A, Axelsson J,
Svensson J, Grafe S, et al. Fluorescence monitoring
of a topically applied liposomal Temoporfin
formulation and photodynamic therapy of
nonpigmented skin malignancies. J Environ Pathol
Tox 2007;26:117–26.
15. Bendsoe N, Persson L, Johansson A, Axelsson J,
Svensson J, Grafe S, et al. Fluorescence monitoring
of a topically applied liposomal temoporfin
formulation and photodynamic therapy of
nonpigmented skin malignancies. J Environ Pathol
Tox 2007;26:117–26.
16. Bernstein ZP, Wilson BD, Oseroff AR, Jones CM,
Dozier SE, Brooks JS, et al. Photofrin photodynamic
therapy for treatment of AIDS-related cutaneous
Kaposi’s sarcoma. AIDS 1999;13:1697–704.
17. Betz CS, Rauschning W, Stranadko EP, Riabov MV,
Albrecht V, Nifantiev NE, et al. Optimization of
treatment parameters for Foscan-PDT of basal cell
carcinomas. Lasers Surg Med 2008;40:300–11.
139